Literature DB >> 16267346

Pathogenesis of chronic obstructive pulmonary disease.

William MacNee1.   

Abstract

The current paradigm for the pathogenesis of chronic obstructive pulmonary disease is that chronic airflow limitation results from an abnormal inflammatory response to inhaled particles and gases in the lung. Airspace inflammation appears to be different in susceptible smokers and involves a predominance of CD8+ T lymphocytes, neutrophils, and macrophages. Studies have characterized inflammation in the peripheral airspaces in different stages of disease severity. Two other processes have received considerable research attention. The first is a protease-antiprotease imbalance, which has been linked to the pathogenesis of emphysema. However, the hypothesis of an increased protease burden associated with functional inhibition of antiproteases has been difficult to prove and is now considered an oversimplification. The second process, oxidative stress, has a role in many of the pathogenic processes of chronic obstructive pulmonary disease and may be one mechanism that enhances the inflammatory response. In addition, it has been proposed that the development of emphysema may involve alveolar cell loss through apoptosis. This mechanism may involve the vascular endothelial growth factor pathway and oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16267346      PMCID: PMC2713323          DOI: 10.1513/pats.200504-045SR

Source DB:  PubMed          Journal:  Proc Am Thorac Soc        ISSN: 1546-3222


  103 in total

1.  Airways obstruction, chronic expectoration, and rapid decline of FEV1 in smokers are associated with increased levels of sputum neutrophils.

Authors:  D Stănescu; A Sanna; C Veriter; S Kostianev; P G Calcagni; L M Fabbri; P Maestrelli
Journal:  Thorax       Date:  1996-03       Impact factor: 9.139

2.  Alveolar inflammation and its relation to emphysema in smokers.

Authors:  R Finkelstein; R S Fraser; H Ghezzo; M G Cosio
Journal:  Am J Respir Crit Care Med       Date:  1995-11       Impact factor: 21.405

3.  Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage.

Authors:  J D Morrow; B Frei; A W Longmire; J M Gaziano; S M Lynch; Y Shyr; W E Strauss; J A Oates; L J Roberts
Journal:  N Engl J Med       Date:  1995-05-04       Impact factor: 91.245

4.  Increased release of ferritin and iron by iron-loaded alveolar macrophages in cigarette smokers.

Authors:  L J Wesselius; M E Nelson; B S Skikne
Journal:  Am J Respir Crit Care Med       Date:  1994-09       Impact factor: 21.405

5.  Increased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary disease.

Authors:  P N Dekhuijzen; K K Aben; I Dekker; L P Aarts; P L Wielders; C L van Herwaarden; A Bast
Journal:  Am J Respir Crit Care Med       Date:  1996-09       Impact factor: 21.405

6.  Upregulation of adhesion molecules in the bronchial mucosa of subjects with chronic obstructive bronchitis.

Authors:  A Di Stefano; P Maestrelli; A Roggeri; G Turato; S Calabro; A Potena; C E Mapp; A Ciaccia; L Covacev; L M Fabbri; M Saetta
Journal:  Am J Respir Crit Care Med       Date:  1994-03       Impact factor: 21.405

7.  Immunodetection of adenoviral E1A proteins in human lung tissue.

Authors:  W M Elliott; S Hayashi; J C Hogg
Journal:  Am J Respir Cell Mol Biol       Date:  1995-06       Impact factor: 6.914

8.  Glutathione homeostasis in alveolar epithelial cells in vitro and lung in vivo under oxidative stress.

Authors:  I Rahman; X Y Li; K Donaldson; D J Harrison; W MacNee
Journal:  Am J Physiol       Date:  1995-09

9.  Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma.

Authors:  V M Keatings; P D Collins; D M Scott; P J Barnes
Journal:  Am J Respir Crit Care Med       Date:  1996-02       Impact factor: 21.405

10.  An investigation of the role of glutathione in increased epithelial permeability induced by cigarette smoke in vivo and in vitro.

Authors:  X Y Li; K Donaldson; I Rahman; W MacNee
Journal:  Am J Respir Crit Care Med       Date:  1994-06       Impact factor: 21.405

View more
  110 in total

1.  Dual function inhibitors of relevance to chronic obstructive pulmonary disease.

Authors:  Dengfeng Dou; Guijia He; Kevin R Alliston; William C Groutas
Journal:  Bioorg Med Chem Lett       Date:  2010-12-10       Impact factor: 2.823

2.  Long-Term Sequelae of Smoking and Cessation in Spontaneously Hypertensive Rats.

Authors:  Ching-Wen Wu; Tammy Yau; Ciara C Fulgar; Savannah M Mack; Alina M Revilla; Nicholas J Kenyon; Kent E Pinkerton
Journal:  Toxicol Pathol       Date:  2019-12-24       Impact factor: 1.902

3.  Evaluation of IL-8 nasal lavage levels and the effects of nasal involvement on disease severity in patients with stable chronic obstructive pulmonary disease.

Authors:  Hacer Celik; Serdar Akpinar; Hayriye Karabulut; Pinar Oktar; Berna Dursun; Huyla Celenk Erguden; Sibel Gunay; Tugrul Sipit
Journal:  Inflammation       Date:  2015-04       Impact factor: 4.092

4.  The Association of Panic Disorder, Posttraumatic Stress Disorder, and Major Depression With Smoking in American Indians.

Authors:  Craig N Sawchuk; Peter Roy-Byrne; Carolyn Noonan; Andy Bogart; Jack Goldberg; Spero M Manson; Dedra Buchwald
Journal:  Nicotine Tob Res       Date:  2015-04-06       Impact factor: 4.244

Review 5.  Comorbidity of heart failure and chronic obstructive pulmonary disease: more than coincidence.

Authors:  Gülmisal Güder; Frans H Rutten
Journal:  Curr Heart Fail Rep       Date:  2014-09

6.  Elevated pulmonary arterial systolic pressure in patients with sarcoidosis: prevalence and risk factors.

Authors:  Aggeliki Rapti; Vasileios Kouranos; Elias Gialafos; Konstantina Aggeli; John Moyssakis; Anastasios Kallianos; Charalampos Kostopoulos; Ourania Anagnostopoulou; Petros P Sfikakis; Athol U Wells; George E Tzelepis
Journal:  Lung       Date:  2012-12-11       Impact factor: 2.584

7.  Inhibition of serine proteases by a new class of cyclosulfamide-based carbamylating agents.

Authors:  Qingliang Yang; Yi Li; Dengfeng Dou; Xiangdong Gan; Swathi Mohan; Christopher S Groutas; Laura E Stevenson; Zhong Lai; Kevin R Alliston; Jiaying Zhong; Todd D Williams; William C Groutas
Journal:  Arch Biochem Biophys       Date:  2008-04-22       Impact factor: 4.013

Review 8.  New concepts in the pathobiology of chronic obstructive pulmonary disease.

Authors:  Victor Kim; Thomas J Rogers; Gerard J Criner
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

9.  Cigarette smoke (CS) and nicotine delay neutrophil spontaneous death via suppressing production of diphosphoinositol pentakisphosphate.

Authors:  Yuanfu Xu; Hongmei Li; Besnik Bajrami; Hyunjeong Kwak; Shannan Cao; Peng Liu; Jiaxi Zhou; Yuan Zhou; Haiyan Zhu; Keqiang Ye; Hongbo R Luo
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-22       Impact factor: 11.205

Review 10.  CT of pulmonary emphysema--current status, challenges, and future directions.

Authors:  Diana Litmanovich; Phillip M Boiselle; Alexander A Bankier
Journal:  Eur Radiol       Date:  2008-09-30       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.